Trial Profile
A trial assessing response and outcome of imatinib in Saudi patients with chronic myeloid leukemia (CML)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 29 Apr 2016 New trial record